ClinicalTrials.gov
public full text
Public Domain
Evaluation of Point-of-Care (EPOC) for COVID-19
EPOC is designed to examine the feasibility of conducting two point-of-care (POC) tests the LumiraDx SARS-CoV-2 Antibody Test and the RightSign COVID-19 IgG/IgM Rapid Test for SARS-CoV-2 antibodies and compare the reproducibility of these tests to tests run at a central laboratory on specimens obtained from the same study participants at the same time.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing#878766
- Safe Return to Regular Clinical Operation After COVID-19 Pandemic#857477
- Comparative Study of Patterns of Immune Response to COVID 19 Vaccination#1173833
- Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine#353325
- Convalescent Plasma for the Treatment of Patients With COVID-19#1009955
Record · ID 1454736
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive